C5a anaphylatoxin chemotactic receptor 1 — Drug Target

All drugs that target C5a anaphylatoxin chemotactic receptor 1 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Complement 5a Receptor Antagonist [EPC] · Complement 5a Receptor Antagonist

Marketed (1)

• Tavneos · Chemocentryx · Complement 5a Receptor Antagonist [EPC] · Rare Disease
  Tavneos blocks the action of a chemical called C5a, which is involved in the body's inflammatory response.